Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trial.
Related ArticlesAdrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trial. J Gastroenterol. 2020 Nov 02;: Authors: Kita T, Ashizuka S, Ohmiya N, Yamamoto T,...
Read More